English
ArabicStamakort 20 Capsules
Stamakort 20 Capsules
Stamakort: Your Pathway to Digestive Wellness
Overview: Stamakort is a groundbreaking dietary supplement, designed to enhance the function of your stomach’s mucosa. Utilizing natural stomach peptides, it addresses peptide deficiency and revitalizes protein synthesis within your stomach cells. Its formulation targets the root cause of common digestive issues, making it a cornerstone in maintaining digestive health.
? Key Features:
- Natural Stomach Peptides: Stamakort’s active ingredients are aimed at rebalancing your digestive system, promoting the repair and functionality of the gastric mucosa.
- Comprehensive Digestive Support: Ideal for individuals experiencing gastritis, Helicobacter pylori infections, peptic ulcers, and more. Stamakort provides a supportive role in managing gastrointestinal, pancreatic, and hepatic conditions.
- Ease of Use: This supplement seamlessly integrates with your existing dietary regime and can be used alongside other supplements and medications for a holistic approach to digestive health.
? Why You Should Buy:
- Broad-Spectrum Benefits: From easing heartburn and abdominal pain to combating the effects of an imbalanced diet and stress, Stamakort is versatile. It’s especially crucial for aging individuals, supporting the stomach’s reduced capacity to produce gastric acid and enzymes.
- Scientifically Backed: Stamakort’s efficacy is rooted in the science of peptide bioregulators, which have shown promise in extending lifespan and enhancing physiological functions through gene expression regulation.
- User-Friendly Regimen: With a simple dosage of 1–2 capsules taken two to three times daily before meals, incorporating Stamakort into your routine is straightforward. A one-month duration, with repeats every 3–6 months, offers flexibility and ease of incorporation into your health regimen.
Embrace Stamakort to nurture your digestive well-being, leveraging the power of peptides to foster a healthier, fuller life. Whether you’re looking to address specific stomach ailments or enhance your overall digestive health, Stamakort stands as a testament to the synergy between nature’s gifts and scientific innovation.
$19.99
Description
BPC-157 promotes gastrointestinal healing, enhances muscle and tendon repair, and has neuroprotective effects, making it beneficial for recovery from injuries and neurological conditions. (PMID: 15840402, 36551977, 37242459)
BPC-157 Research Topics:
-
Gastrointestinal Healing:
BPC-157 has been shown to significantly aid in healing inflammatory bowel disease and other gastrointestinal conditions by promoting tissue repair and reducing inflammation. (PMID: 15840402) -
Muscle and Tendon Healing:
This peptide enhances the healing of muscles, tendons, and ligaments, making it beneficial for recovery from injuries. (PMID: 36551977) -
Neuroprotective Effects:
BPC-157 supports brain-gut axis functions and has potential neuroprotective effects, aiding in the recovery of neurological functions. (PMID: 37242459)
Peer-Reviewed Studies
Seiwerth, S., Sikiric, P., Grabarevic, Z., Zoricic, I., Hanzevacki, M., Ljubanovic, D., … & Kolega, Z. (1997)
Journal of Physiology-Paris, 91(3-5), 173-178.
Staresinic, M., Petrovic, I., Novinscak, T., Jukic, I., Pevec, D., Suknaic, S., … & Sikiric, P. (2006)
Journal of orthopaedic research, 24(5), 1109-1117.
Structure
Source: PubChem
Sequence: Gly- Glu-Pro-Pro-Pro-Gly-Lys-Pro-AlaAsp-Asp-Ala-Gly-Leu-Val
Molecular Formula: Cs2HgaN1s022
Molecular Weight: 1419.556 g/mol
PubChem CID: 108101
Referenced Citations
- T. Huang et al., “Body protective compound-157 enhances alkali-burn wound healing and Promotes Proliferation, migration, and angiogenesis in vitro,” Drug Des. Devel. Ther., vol. 9, RR- 2485-2499, 2015.
- D. Drmic et al., “Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine,” World J. Gastroenterol.1 vol. 24, no. 48, pp. 5462-5476, Dec. 2018.
- F. Amie et al., “By Passing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and Larginine,” World J. Gastroenterol.1 vol. 24, no. 47, QQ. 5366-5378, Dec. 2018.
- A. Duzel et al., “Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights,” World J. Gastroenterol., vol. 23, no. 48, QQ. 8465-8488, Dec. 2017.
- J. Vukojevic et al., “Rat inferior caval vein_{ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157,” Vascul. Pharmacol., vol. 106, QQ. 54- 66, 2018.
- D. Drmic et al., “Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME,” World J. Gastroenterol., vol. 23, no. 29, QQ. 5304- 5312, Aug. 2017.
- M.-J. Hsieh et al., “Therapeutic Potential of Pro-angiogenic BPC157 is associated with VEGFR2 activation and LIQ-regulation,” J. Mol. Med. Berl. Ger., vol. 95, no. 3, QQ. 323- 333, 2017.
- Z. Grabarevic et al., “The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks,” J. Physiol. Paris, vol. 91, no. 3-51 P- 139-149, Oct. 1997.
- P. Sikiric et al., “Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing,” Curr. Pharm. Des., vol. 24, no. 18, pp. 1990-2001, 2018.
- S. Seiwerth et al., “BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing,” Curr. Pharm. Des., vol. 24, no. 18, pp. 1972-1989, 2018.
- C.-H. Chang, W.-C. Tsai, M.-S. Lin, Y.-H. Hsu, and J.-H. S. Pang, “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration,” J. Appl. Physiol., vol. 110, no. 3, pp. 774-780, Oct. 2010.
- Y.-L. Hu et al., “FAK and paxillin dynamics at focal adhesions in the protrusions of migrating cells,” Sci. Rep., vol. 41 p. 6024, Aug. 2014.
- K. Skrlec et al., “Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities,” ppl. Microbial. Biotechnol., vol. 102, no. 23, pp. 10103-10117, Dec. 2018.
- D. Strinic et al., “BPC 157 counteracts QTc prolongation induced by haloperidol, flurhenazine, clozapine, olanzapine, quetiapine. sulpiride, and metoclopramide in rats,” Life Sci., vol. 186, RR- 66-79, Oct. 2017.
- N. Jelovac et al. 1 “Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy. and gastric ulcers in mice and rats,” Eur. J. Pharmacol., vol. 379, no. 1, PR· 19-31, Aug.:. 1999.
- I. Tlak Gajger, J. Ribaric, M. Smodis Skerl, J. Vlainic, and P. Sikiric, “Stable gastric pentadecapeptide BPC 157 in honeybee (Apiis mellifera) therapv, to control Nosema ceranae invasions in apiary. conditions,” J. Vet. Pharmacol. Ther., vol. 41, no. 4, pp. 614- 621, Aug. 2018.
Reviews
There are no reviews yet.